An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia.

Mid-graft flow through TEVGs displayed a decreasing trend between weeks 2 and 4 ( P = 0.06) and reached a steady-state level of flow thereafter (Fig. 4a ; no significant differences were detected between flow rates at 4, 12, and 24 weeks, P > 0.2).

also in 47,180 other papers